If you’d talked to Joe Heyman around the 2000s, you might have taken him as a telemedicine naysayer. Back then, the Massachusetts OB-GYN was highly skeptical of the rash of new services sprouting up to remotely connect patients and physicians. He was wary, he told STAT, of patients “calling a total stranger and asking for clinical care,” and worried about building trust when a new doctor picked up the phone every time. He never once conducted a visit via video by the time he retired from seeing patients in 2014.

He only wishes he’d had the chance.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy